2022
DOI: 10.1016/j.nicl.2022.103220
|View full text |Cite
|
Sign up to set email alerts
|

The spatio-temporal relationship between white matter lesion volume changes and brain atrophy in clinically isolated syndrome and early multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
2

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 30 publications
0
6
0
Order By: Relevance
“…Future studies should focus not only on the correlations within the same time interval but should also investigate the relationships between WM lesion changes and subsequent brain atrophy and vice versa. This has been addressed in a separate paper for the present dataset ( Mattiesing et al, 2022 ).…”
Section: Discussionmentioning
confidence: 89%
“…Future studies should focus not only on the correlations within the same time interval but should also investigate the relationships between WM lesion changes and subsequent brain atrophy and vice versa. This has been addressed in a separate paper for the present dataset ( Mattiesing et al, 2022 ).…”
Section: Discussionmentioning
confidence: 89%
“…Data availability and quality 11 allowed the quantification of atrophy in 169 patients, that is global atrophy (PBVC m24–m60 : −1.009 ± 0.967%) and central atrophy (PVVC m24–m60 : 7.511 ± 9.117%) from month 24 to month 60. Results of the stepwise forward linear regressions for models 1 and 2 are shown in Table 2 .…”
Section: Resultsmentioning
confidence: 99%
“…The REFLEX/REFLEXION studies lasted from 16 November 2006 until 30 August 2013. 12 Only those patients who started treatment immediately at the beginning of REFLEX ( N = 262), 11 the early treatment group, were included in this study. This was chosen due to the study design, as patients in the delayed treatment group started treatment immediately after conversion to clinically definite multiple sclerosis (CDMS), resulting in lowered probabilities of progression in this subgroup over time.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations